These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 9515017

  • 1. U50,488H inhibits effects of norepinephrine in rat cardiomyocytes-cross-talk between kappa-opioid and beta-adrenergic receptors.
    Yu XC, Li HY, Wang HX, Wong TM.
    J Mol Cell Cardiol; 1998 Feb; 30(2):405-13. PubMed ID: 9515017
    [Abstract] [Full Text] [Related]

  • 2. Anti-arrhythmic effect of kappa-opioid receptor stimulation in the perfused rat heart: involvement of a cAMP-dependent pathway.
    Yu XC, Wang HX, Pei JM, Wong TM.
    J Mol Cell Cardiol; 1999 Oct; 31(10):1809-19. PubMed ID: 10525419
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Phospholipase C inhibitors attenuate arrhythmias induced by kappa-receptor stimulation in the isolated rat heart.
    Bian JS, Zhang WM, Xia Q, Wong TM.
    J Mol Cell Cardiol; 1998 Oct; 30(10):2103-10. PubMed ID: 9799662
    [Abstract] [Full Text] [Related]

  • 5. kappa-opioid receptor stimulation inhibits cardiac hypertrophy induced by beta1-adrenoceptor stimulation in the rat.
    Shan D, Wang H, Su Y, Jing Y, Wong TM.
    Eur J Pharmacol; 2007 Jan 26; 555(2-3):100-5. PubMed ID: 17126321
    [Abstract] [Full Text] [Related]

  • 6. Role of protein kinase C-epsilon in the development of kappa-opioid receptor tolerance to U50,488H in rat ventricular myocytes.
    Zhou JJ, Bian JS, Pei JM, Wu S, Li HY, Wong TM.
    Br J Pharmacol; 2002 Apr 26; 135(7):1675-84. PubMed ID: 11934807
    [Abstract] [Full Text] [Related]

  • 7. Effects of kappa-opioid receptor stimulation in the heart and the involvement of protein kinase C.
    Bian JS, Wang HX, Zhang WM, Wong TM.
    Br J Pharmacol; 1998 Jun 26; 124(3):600-6. PubMed ID: 9647487
    [Abstract] [Full Text] [Related]

  • 8. kappa-Opioid receptor stimulation inhibits augmentation of Ca(2+) transient and hypertrophy induced by isoprenaline in neonatal rat ventricular myocytes - Role of CaMKIIdelta(B).
    Wu G, Wang H, Yang J, Yang Y, Liu C, Jing L, Wong TM.
    Eur J Pharmacol; 2008 Oct 24; 595(1-3):52-7. PubMed ID: 18721804
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of [3H]-U69593 binding and the cardiac effects of U50, 488H by calcium channel blockers in the rat heart.
    Zhang WM, Wang HX, Xia Q, Wong TM.
    Br J Pharmacol; 1997 Mar 24; 120(5):827-32. PubMed ID: 9138688
    [Abstract] [Full Text] [Related]

  • 10. Reduced inhibitory actions of adenosine A1 and kappa 1-opioid receptor agonists on beta-adrenoceptors in spontaneously hypertensive rat heart.
    Yu XC, Wang HX, Wong TM.
    Clin Exp Pharmacol Physiol; 1997 Dec 24; 24(12):976-7. PubMed ID: 9406669
    [Abstract] [Full Text] [Related]

  • 11. kappa -opioid receptor stimulation induces arrhythmia in the isolated rat heart via the protein kinase C/Na(+)-H(+)exchange pathway.
    Bian JS, Pei JM, Cheung CS, Zhang WM, Wong TM.
    J Mol Cell Cardiol; 2000 Aug 24; 32(8):1415-27. PubMed ID: 10900168
    [Abstract] [Full Text] [Related]

  • 12. U50,488H-induced internalization of the human kappa opioid receptor involves a beta-arrestin- and dynamin-dependent mechanism. Kappa receptor internalization is not required for mitogen-activated protein kinase activation.
    Li JG, Luo LY, Krupnick JG, Benovic JL, Liu-Chen LY.
    J Biol Chem; 1999 Apr 23; 274(17):12087-94. PubMed ID: 10207034
    [Abstract] [Full Text] [Related]

  • 13. Activation of the cloned human kappa opioid receptor by agonists enhances [35S]GTPgammaS binding to membranes: determination of potencies and efficacies of ligands.
    Zhu J, Luo LY, Li JG, Chen C, Liu-Chen LY.
    J Pharmacol Exp Ther; 1997 Aug 23; 282(2):676-84. PubMed ID: 9262330
    [Abstract] [Full Text] [Related]

  • 14. Stimulation of kappa-opioid receptor reduces isoprenaline-induced cardiac hypertrophy and fibrosis.
    Yin W, Zhang P, Huang JH, Zhang QY, Fan R, Li J, Zhou JJ, Hu YZ, Guo HT, Zhang SM, Wang YM, Kaye AD, Gu CH, Liu JC, Cheng L, Cui Q, Yi DH, Pei JM.
    Eur J Pharmacol; 2009 Apr 01; 607(1-3):135-42. PubMed ID: 19233160
    [Abstract] [Full Text] [Related]

  • 15. Suppression of cAMP by phosphoinositol/Ca2+ pathway in the cardiac kappa-opioid receptor.
    Zhang WM, Wong TM.
    Am J Physiol; 1998 Jan 01; 274(1):C82-7. PubMed ID: 9458715
    [Abstract] [Full Text] [Related]

  • 16. Effects of U50488 and bremazocine on [Ca2+]i and cAMP in naive and tolerant rat ventricular myocytes: evidence of kappa opioid receptor multiplicity in the heart.
    Zhang WM, Wu S, Yu XC, Wang HX, Bian JS, Wong TM.
    J Mol Cell Cardiol; 1999 Feb 01; 31(2):355-62. PubMed ID: 10093048
    [Abstract] [Full Text] [Related]

  • 17. Pro- and anti-arrhythmic effects of a kappa opioid receptor agonist: a model for the biphasic action of a local hormone in the heart.
    Yu X, Zhang W, Bian J, Wong TM.
    Clin Exp Pharmacol Physiol; 1999 Oct 01; 26(10):842-4. PubMed ID: 10549419
    [Abstract] [Full Text] [Related]

  • 18. [Delayed electrical uncoupling is involved in kappa-opioid receptor activation -induced cardioprotective effect in the isolated rat heart].
    Chen BP, Fan FY, Mao HJ, Xia Q.
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2006 Feb 01; 22(1):64-70. PubMed ID: 21186583
    [Abstract] [Full Text] [Related]

  • 19. Kappa-opioid receptor stimulation inhibits growth of neonatal rat ventricular myocytes.
    Wang G, Wang H, Yang Y, Wong TM.
    Eur J Pharmacol; 2004 Sep 13; 498(1-3):53-8. PubMed ID: 15363975
    [Abstract] [Full Text] [Related]

  • 20. Kappa-opioid receptor agonist inhibits the cholera toxin-sensitive G protein in the heart.
    Yu XC, Diao TM, Pei JM, Zhang WM, Wong NS, Wong TM.
    J Cardiovasc Pharmacol; 2001 Aug 13; 38(2):232-9. PubMed ID: 11483873
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.